{{Drugbox
| Watchedfields = changed
| verifiedrevid = 477239146
| IUPAC_name = ''N''-Hydroxyacetamide
| image = Acetohydroxamic acid.svg
| image2 = Acetohydroxamic-acid-3D-balls.png
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CDI|acetohydroxamic_acid}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 546-88-3
| ATC_prefix = G04
| ATC_suffix = BX03
| ATC_supplemental =  
| PubChem = 1990
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00551
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 1913
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 4RZ82L2GY5
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00220
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 49029
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 734
<!--Chemical data-->
| C=2 | H=5
| N=1 | O=2
| molecular_weight = 75.0666 g/mol
| smiles = O=C(NO)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RRUDCFGSUDOHDG-UHFFFAOYSA-N
}}

'''Acetohydroxamic acid''' (also known as '''AHA''' or '''Lithostat''') is a [[drug]] that is a potent and irreversible inhibitor of [[bacteria]]l and [[plant]] [[urease]] usually used for [[urinary tract]] [[infection]]s. The molecule is similar to [[urea]] but is not hydrolyzable by the urease enzyme.<ref name="Fishbein">{{cite journal |author1=W.  Fishbein |author2=P. Carbone  |journal=J Biol Chem |title=Urease catalysis. ii. Inhibition of the enzyme by hydroxyurea, hydroxylamine, and acetohydroxamic acid|date=June 1965 |volume=240 |pages=2407–14}}</ref>

==Orphan drug==

In 1983 the US [[Food and Drug Administration]] approved acetohydroxamic acid (AHA) as an [[orphan drug]] for "prevention of so-called struvite stones" under the newly enacted [[Orphan Drug Act of 1983]].<ref name="JAMA_1983">{{cite journal |title=New drugs selectively inhibit kidney stone formation |first=Charles |last=Marwick |journal=The Journal of the American Medical Association |date=1983 |volume=240 |number=3 |pages=321–322 |doi=10.1001/jama.1983.03340030003001 }}</ref> AHA cannot be patented because it is a standard chemical compound.<ref name="JAMA_1983" />

== References ==
{{reflist}}

==See also==
* [[Salicylhydroxamic acid]]

{{Urologicals}}

[[Category:Orphan drugs]]
[[Category:Hydroxamic acids]]


{{genito-urinary-drug-stub}}